Page 1 | Search Results | Blood | American Society of Hematology

1-10 of 10

Sort by

Sort Order Select

Journal Articles

Follow Up On CD8-Depleted Donor-Lymphocyte Infusions After T-Cell Depleted Allogeneic Hemopoietic Stem Cell Transplantation

Eva Maria Wagner, MD, Daniela Wehler, MD, Timo Schmitt, MD, Aline N. Lay, Karin Kolbe, MD, Matthias Theobald, MD, PhD, Wolfgang Herr, MD, Ralf G Meyer, MD

Blood (2013) 122 (21): 4526.

https://doi.org/10.1182/blood.V122.21.4526.4526

Published: 2013

Journal Articles

Impact of Prophylactic CD8-Depleted Donor-Lymphocyte Infusions After Allogeneic Hematopoietic Stem Cell Transplantation and Alemtuzumab Mediated T-Cell Depletion,

Eva M Wagner, MD, Daniela Wehler, MD, Karin Kolbe, MD, Matthias Theobald, MD, PhD, Wolfgang Herr, MD, Ralf G Meyer, MD

Blood (2011) 118 (21): 4109.

https://doi.org/10.1182/blood.V118.21.4109.4109

Published: 2011

Journal Articles

Prior Treatment with Alemtuzumab Interferes with T-Cell Engraftment After Allogeneic Stem Cell Transplantation in Patients with Chronic Lymphocytic Leukemia.

Johannes Schetelig, Christian Thiede, Alexander Kiani, Uwe Platzbecker, Uta Oelschlaegel, Matthias Haenel, Gaby Geissler, Rainer Schwerdtfeger, MD, Karin Kolbe, MD, Martin Kaufmann, Matthias Zeis, MD, Kerstin Schaefer-Eckart, MD, Wolfgang Siegert, MD, PhD, Gerhard Ehninger

Blood (2009) 114 (22): 3351.

https://doi.org/10.1182/blood.V114.22.3351.3351

Published: 2009

Journal Articles

Relevance of the Hematopoietic Cell Transplantation-Specific Comorbidity Index (HCT-CI) On Non-Relapse Related Mortality (NRM) in Patients with Acute Lymphoblastic Leukemia (ALL) Receiving Allogeneic Hematopoietic Stem Cell Transplantation (HSCT) in First Complete Remission: Results From the GMALL Study Group.

Matthias Stelljes, MD, Mareike David, Renate Arnold, MD, Dietrich W Beelen, MD, Wolfgang A Bethge, MD, Martin Bornhäuser, MD, Jolanta Dengler, MD, Juergen Finke, MD, Hans J Kolb, MD, Karin Kolbe, MD, Nicolaus Kröger, MD, Dietger Niederwieser, MD, Wolf Rösler, MD, Rainer Schwerdtfeger, MD, Joachim Kienast, MD, Nicola Goekbuget, MD, Dieter Hoelzer, MD, PhD

Blood (2009) 114 (22): 3352.

https://doi.org/10.1182/blood.V114.22.3352.3352

Published: 2009

Journal Articles

Autologous Hematopoietic Stem Cell Transplantation (autoHSCT) in CLL: First Results of An EBMT Randomized Trial Comparing Autotransplant Versus Wait and Watch.

Mauricette Michallet, MD, PhD, Peter Dreger, MD, PhD, Laurent Sutton, MD, Ronald Brand, Sue Richards, Anja van Biezen, Mohamad Sobh, Pharm.M, Alois Gratwohl, MD, Karin Kolbe, MD, Claire E. Dearden, MD, Michael Hallek, T. M. de Witte, MD, PhD, Dietger W. Niederwieser, MD, Michel Leporrier, MD, Donald Milligan, MD

Blood (2009) 114 (22): 877.

https://doi.org/10.1182/blood.V114.22.877.877

Published: 2009

Journal Articles

CD8-Depleted Donor Lymphocyte Infusions Convert Mixed into Complete Donor T-Cell Chimerism after T-Cell Depleted Allogeneic Stem Cell Transplantation.

Ralf G Meyer, MD, Eva M Wagner, MD, Timo Schmitt, Klaus Bender, PhD, Udo F Hartwig, PhD, Christoph Huber, MD, Karin Kolbe, MD, Wolfgang Herr, MD

Blood (2008) 112 (11): 2160.

https://doi.org/10.1182/blood.V112.11.2160.2160

Published: 2008

Journal Articles

Improved Outcome for Patients with Acute Myeloid Leukemia (AML) and Myelodysplastic Syndrome (MDS) with Poor Risk Cytogenetics – Result from An Analysis on 172 Patients Receiving FLAMSA-RIC Conditioning for Allogeneic Stem Cell Transplantatioin (SCT).

Blood (2008) 112 (11): 1971.

https://doi.org/10.1182/blood.V112.11.1971.1971

Published: 2008

Journal Articles

Chimerism Analysis of Langerhans Cells Early after T Cell Depleted Allogeneic Hematopoietic Stem Cell Transplantation.

Timo Schmitt, Kerstin Schneiker, Abdo Konur, PhD, Ali Hadian, MD, Klaus Bender, PhD, Esther von Stebut, MD, Karin Kolbe, MD, Christoph Huber, MD, Wolfgang Herr, MD, Ralf G. Meyer, MD

Blood (2007) 110 (11): 3249.

https://doi.org/10.1182/blood.V110.11.3249.3249

Published: 2007

Journal Articles

Preemptive Transfer of GMP-Grade CD8-Depleted Donor Lymphocytes after T-Cell Depleted Reduced-Intensity Transplantation.

Ralf G. Meyer, MD, Cedrik M. Britten, MD, Abdo Konur, PhD, Klaus Bender, PhD, Daniela Wehler, MD, Udo Hartwig, PhD, Thomas C. Wehler, MD, Chiara Gentilini, MD, Lutz Uharek, MD, Christoph Huber, MD, Karin Kolbe, MD, Wolfgang Herr, MD

Blood (2005) 106 (11): 297.

https://doi.org/10.1182/blood.V106.11.297.297

Published: 2005

Journal Articles

Campath-1H-Based Reduced-Intensity Conditioning Followed by Allogeneic Blood Stem-Cell Transplantation and Preemptive CD8-Depleted Donor Lymphocyte Infusions.

Ralf G. Meyer, MD, Daniela Wehler, MD, Thomas C. Wehler, MD, Cedrik M. Britten, MD, Alexander Burchardt, MD, Udo Hartwig, PhD, Christoph Huber, MD, Karin Kolbe, MD, Wolfgang Herr, MD

Blood (2004) 104 (11): 5069.

https://doi.org/10.1182/blood.V104.11.5069.5069

Published: 2004

NARROW

Follow Up On CD8-Depleted Donor-Lymphocyte Infusions After T-Cell Depleted Allogeneic Hemopoietic Stem Cell Transplantation

Impact of Prophylactic CD8-Depleted Donor-Lymphocyte Infusions After Allogeneic Hematopoietic Stem Cell Transplantation and Alemtuzumab Mediated T-Cell Depletion,

Prior Treatment with Alemtuzumab Interferes with T-Cell Engraftment After Allogeneic Stem Cell Transplantation in Patients with Chronic Lymphocytic Leukemia.

Autologous Hematopoietic Stem Cell Transplantation (autoHSCT) in CLL: First Results of An EBMT Randomized Trial Comparing Autotransplant Versus Wait and Watch.

CD8-Depleted Donor Lymphocyte Infusions Convert Mixed into Complete Donor T-Cell Chimerism after T-Cell Depleted Allogeneic Stem Cell Transplantation.

Improved Outcome for Patients with Acute Myeloid Leukemia (AML) and Myelodysplastic Syndrome (MDS) with Poor Risk Cytogenetics – Result from An Analysis on 172 Patients Receiving FLAMSA-RIC Conditioning for Allogeneic Stem Cell Transplantatioin (SCT).

Chimerism Analysis of Langerhans Cells Early after T Cell Depleted Allogeneic Hematopoietic Stem Cell Transplantation.

Preemptive Transfer of GMP-Grade CD8-Depleted Donor Lymphocytes after T-Cell Depleted Reduced-Intensity Transplantation.

Campath-1H-Based Reduced-Intensity Conditioning Followed by Allogeneic Blood Stem-Cell Transplantation and Preemptive CD8-Depleted Donor Lymphocyte Infusions.

Email alerts

ASH Publications

American Society of Hematology

Email alerts

ASH Publications

American Society of Hematology

This Feature Is Available To Subscribers Only